$MRKR 3 SEC Filings

Filed On	Filing
04 Nov 2025	Form 3: Corzo Kathryn Penkus, Director No securities owned
05 Jul 2023	Form 3: Lurier Eliot M, Interim CFO No securities owned
09 Dec 2021	Form 3: Knobil Katharine, Director Holds 1,500 shares of Common Stock
12 Mar 2020	Form 3: Szymanska Anna, Vice President, Quality
12 Mar 2020	Form 3: Garrett Gerald, Vice President, Clinical Ops.
19 Aug 2019	Form 3: Agopyan Nadia, VP, Regulatory Affairs No securities owned
08 Aug 2019	Form 3: Elms Steve, Director Holds 2,000,000 shares of Common Stock
15 May 2019	Form 3: Koneru Mythili, Snr VP, Clinical Development
28 Dec 2018	Form 3: Leen Ann M., Chief Scientific Officer Holds 1,993,059 shares of Common Stock
28 Dec 2018	Form 3: Hoang Tsvetelina P, VP, Research and Development Holds 179,711 shares of Common Stock
28 Dec 2018	Form 3: Moseley Ken, General Counsel No securities owned
29 Nov 2018	Form 3: Kim Anthony H., Chief Financial Officer No securities owned
19 Oct 2018	Form 3: Vera Juan, Director Holds 1,993,059 shares of Common Stock
19 Oct 2018	Form 3: Wilson John Robert, Director Holds 6,060,783 shares of Common Stock
19 Oct 2018	Form 3: Eansor Norman David, Director No securities owned
18 Oct 2018	Form 3: Walker Paul Edward, Director Holds 5,000,000 shares of Common Stock
18 Oct 2018	Form 3: Viswanathan Ravi, 10% owner Holds 5,000,000 shares of Common Stock
18 Oct 2018	Form 3: Sonsini Peter W., 10% owner Holds 5,000,000 shares of Common Stock
18 Oct 2018	Form 3: Sandell Scott D, 10% owner Holds 5,000,000 shares of Common Stock
18 Oct 2018	Form 3: Mott David M, 10% owner Holds 5,000,000 shares of Common Stock

Comments